8.3.1 Hormone responsive prostate cancer

NICE NG131: Prostate cancer: diagnosis and management

All GnRH analogues are equally effective and specialists will continue to recommend treatment with a 'GnRH analogue' rather than a specific brand of product unless clinically indicated.
Specialists agree that GPs can change the product prescribed within this class of therapy to complete courses of therapy for existing patients as clinically appropriate and after informed discussions with the patient.

For prescribing related to the treatment of gender dysphoria please see:

Shared Care Prescribing Guidance for Treatment of Gender Dysphoria in People Assigned Male at Birth Transitioning to a Feminine Gender Identity

Shared Care Prescribing Guidance for Treatment of Gender Dysphoria In People Assigned Female at Birth Transitioning to a Masculine Gender Identity